America's Best Nonprofits
  1. Home
  2. Philanthropy & Grantmaking
  3. Chicago, IL
  4. Foundation for Sarcoidosis Research

Foundation for Sarcoidosis Research

Foundation for Sarcoidosis Research is ranked #3 of 46 philanthropy & grantmaking organizations in Chicago, IL, with an America's Best Score of 86 out of 100, based on its 2025 Form 990.

  • Chicago, IL
  • Tax-exempt since 2012
  • EIN: 36-4378232
stopsarcoidosis.org ProPublica Charity Navigator
Is this your organization? Claim it Tax filings by year Nominate
86OF 100 #3 of 46 in Chicago ranked philanthropy & grantmaking organizations How this score is calculated

Organization summary

Foundation for Sarcoidosis Research is a 501(c)(3) organization, classified under Philanthropy & Grantmaking (NTEE T31). Contributions are tax-deductible.

320 W Ohio St, Chicago, IL 60654-6566

Among the 72 scored philanthropy & grantmaking organizations in Chicago, Foundation for Sarcoidosis Research holds 55.7 months of operating reserves (peer median 12.1 months), runs a typical yearly surplus of 14.7% (peers: surplus of 2.3%), and has grown spending 23.4% a year (peers: grown spending 4.8% a year).

In fiscal year 2025 it reported $4,662,058 in revenue and $3,810,958 in expenses, with contributions making up 85.5% of revenue.

Work here? Claim this profile to add your mission, programs and logo.

What it does

From its own Form 990, as filed with the IRS

Mission · 2025 Form 990

The Foundation for Sarcoidosis Research (fsr) is the leading international organization dedicated to finding a cure for sarcoidosis and improving care for sarcoidosis patients through research, education, and support. Since its establishment in 2000, fsr has fostered over $7.5 million in sarcoidosis specific research efforts.

Largest programs · fiscal year 2025

  • Fsr research funding - the Foundation for Sarcoidosis Research provided $875,600 in sarcoidosis research funding in 2025. Fsr provided three fellowships in the amount of $150,000 each, two cardiac grants in the amount of $100,000 each, two pilot grants in the amounts of $100,000 and $99,600, and one fsr/American heart association partner grant in the amount of $26,000. Fsr also hosts a patient reg… Read more

    Fsr research funding - the Foundation for Sarcoidosis Research provided $875,600 in sarcoidosis research funding in 2025. Fsr provided three fellowships in the amount of $150,000 each, two cardiac grants in the amount of $100,000 each, two pilot grants in the amounts of $100,000 and $99,600, and one fsr/American heart association partner grant in the amount of $26,000. Fsr also hosts a patient registry with nearly 7,500 participants from 68 countries and provides ongoing support to academia and industry in ensuring all clinical trials and research are patient centered.

    $1,553,084 spent · 54.2% of program spending
  • Fsr global sarcoidosis clinic alliance (fsr-gsca) clinical support - comprised of 46 member institutions, the fsr-gsca is a powerful network of institutions that support patients, caregivers, and clinicians, through educational and support programming. The fsr-gsca reaches over 4000 clinicians with clinical education programming from over 40 countries. Through this program, fsr coordinates continu… Read more

    Fsr global sarcoidosis clinic alliance (fsr-gsca) clinical support - comprised of 46 member institutions, the fsr-gsca is a powerful network of institutions that support patients, caregivers, and clinicians, through educational and support programming. The fsr-gsca reaches over 4000 clinicians with clinical education programming from over 40 countries. Through this program, fsr coordinates continuing education educational programs for clinicians including the fsr clinical education and engagement series, the fsr journal club, and the fsr case conference program, which provide insights that lead to practice changing behavior by attendees and participants. Fsr is now supporting regional clinical education meetings through program and marketing support to reach beyond experts to the pool of local physicians and advanced practitioners.

    $1,096,474 spent · 38.3% of program spending
  • Fsr patient support and education - fsr provides extensive support to patient and caregivers impacted by sarcoidosis through information & referral services, assistance to financial resources, 1:1 peer to peer patient support program (patient navigators), national virtual support group, and local support groups affiliated with the fsr global sarcoidosis clinic alliance. Fsr hosts webinars, town ha… Read more

    Fsr patient support and education - fsr provides extensive support to patient and caregivers impacted by sarcoidosis through information & referral services, assistance to financial resources, 1:1 peer to peer patient support program (patient navigators), national virtual support group, and local support groups affiliated with the fsr global sarcoidosis clinic alliance. Fsr hosts webinars, town halls, podcasts, virtual summits, and in-person educational events to provide patients and family members with education from world-renowned sarcoidosis experts. Fsr works with the nih, fda, and dod to ensure the sarcoidosis is considered in all aspects for federal research and drug development. Fsr is committed to ensuring clinical trials represent all in our community and has been leading efforts to reduce barriers to clinical trial access, including coverage under fmla and paid time off.

    $215,975 spent · 7.5% of program spending

Where each dollar went · fiscal year 2025

Of every dollar it spent, 75¢ went to programs, 18¢ to management and 7¢ to fundraising.

  • Programs $2,865,533
  • Management $681,883
  • Fundraising $263,542

In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.

America's Best Score

Free assessmentMethodology
Score86 / 100
Rank in Chicago#3 of 46
DesignationRanked

Score breakdown

MeasureThis organizationPoints
Operating reserves55.7 mo; 14.9 mo in cash25 / 25
Financial balance (median margin)+14.7%10 / 20
Transparency4 full 990s, latest TY202520 / 20
Program growth+23.4% / yr15 / 15
Track record14 years5.6 / 10
Debt load5.9% of assets10 / 10
Total85.6 → 86
Spending on programs
Not scored; America's Best needs 65%+
75%Meets

Compared with Chicago peers

MeasureThis organizationPeer median
Operating reserves55.7 mo12.1 mo
Typical margin+14.7%+2.3%
Spending growth+23.4% / yr+4.8% / yr
Debt load5.9%5.9%

Peers: the 72 Chicago philanthropy & grantmaking organizations with a score, ranked or below the bar.

Tax filings by year

Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.

Revenue$4,662,058Fiscal year 20252022: $1,673,59920222023: $2,574,10420232024: $13,585,86520242025: $4,662,0582025
Expenses$3,810,958Fiscal year 20252022: $2,027,94520222023: $2,402,43620232024: $3,368,01620242025: $3,810,9582025
Total assets$18,793,381Fiscal year 20252022: $4,929,85420222023: $5,742,89520232024: $17,183,15820242025: $18,793,3812025
Total liabilities$1,107,498Fiscal year 20252022: $384,85620222023: $455,89920232024: $1,172,43120242025: $1,107,4982025
Fiscal year ending December 2025
Revenue$4,662,058
Expenses$3,810,958
Net income$851,100
Net assets$17,685,883

Notable sources of revenue

Percent of total revenue
Contributions$3,985,033
Program services$97,267
Investment income$717,533
Other (net)−$137,775

Assets / debt

Total assets$18,793,381
Total liabilities$1,107,498
Net assets$17,685,883

Compensation

Not in our extract for this year.

Fiscal year ending December 2024
Revenue$13,585,865
Expenses$3,368,016
Net income$10,217,849
Net assets$16,010,727

Notable sources of revenue

Percent of total revenue
Contributions$13,025,070
Program services$192,325
Investment income$364,032
Other (net)$4,438

Assets / debt

Total assets$17,183,158
Total liabilities$1,172,431
Net assets$16,010,727

Compensation

Not in our extract for this year.

Fiscal year ending December 2023
Revenue$2,574,104
Expenses$2,402,436
Net income$171,668
Net assets$5,286,996

Notable sources of revenue

Percent of total revenue
Contributions$2,411,412
Program services$252,937
Investment income$143,978
Other (net)−$234,223

Assets / debt

Total assets$5,742,895
Total liabilities$455,899
Net assets$5,286,996

Compensation

Officers and key employees$416,000
Share of expenses17.3%
Fiscal year ending December 2022
Revenue$1,673,599
Expenses$2,027,945
Net income−$354,346
Net assets$4,544,998

Notable sources of revenue

Percent of total revenue
Contributions$1,291,209
Program services$341,425
Investment income$119,287
Other (net)−$78,322

Assets / debt

Total assets$4,929,854
Total liabilities$384,856
Net assets$4,544,998

Compensation

Officers and key employees$246,000
Share of expenses12.1%

About this data

Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?